[theold]

HMG has alleged that the company is in breach of its obligations under the supply agreement, but the company strenuously denies this.

Despite the UK Government’s unexpected withdrawal from the agreement, the company says it will be continuing its vaccine development plan.

The vaccine is currently being used in Phase 3 clinical trials with Public Health England, with results set to be announced in October.


https://www.bbc.com/news/business-58499064